Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
出版年份 2022 全文链接
标题
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-31
DOI
10.1038/s41416-022-01732-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantile regression models for survival data with missing censoring indicators
- (2021) Zhiping Qiu et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- 751P Survival prognostic and surrogate values of the early modeled CA-125 KELIM in newly diagnosed advanced ovarian cancer: Data from the GCIG meta-analysis group
- (2021) P. Corbaux et al. ANNALS OF ONCOLOGY
- The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas
- (2021) Benoit You et al. CANCER TREATMENT REVIEWS
- Differential benefit from fractionated dose-dense first-line chemotherapy for epithelial ovarian cancer (EOC) according to KELIM-evaluated tumor primary chemosensitivity: Exploratory analyses of ICON-8 trial.
- (2021) Benoit You et al. JOURNAL OF CLINICAL ONCOLOGY
- CA-125 ELIMination rate constant K (KELIM) Is A Marker Of Chemosensitivity In Patients With Ovarian Cancer: Results from the Phase II CHIVA trial
- (2020) Benoît You et al. CLINICAL CANCER RESEARCH
- The forefront of ovarian cancer therapy: update on PARP inhibitors
- (2020) M.R. Mirza et al. ANNALS OF ONCOLOGY
- Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial
- (2020) Paul DiSilvestro et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
- (2020) William P. Tew et al. JOURNAL OF CLINICAL ONCOLOGY
- 847P The prognostic value of chemosensitivity, estimated by the modeled CA-125 KELIM, in ovarian cancer patients treated with neo-adjuvant chemotherapy in the Netherlands
- (2020) L. Van Wagensveld et al. ANNALS OF ONCOLOGY
- Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by BRCA and homologous recombination status: PRIMA/ENGOT-OV26/GOG-3012 study
- (2020) B.J. Monk et al. GYNECOLOGIC ONCOLOGY
- Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
- (2019) Olivier Colomban et al. CLINICAL CANCER RESEARCH
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started